Date: 7th May, Tuesday
Inflammation Resolution: A New Paradigm to Treat Inflammation
It is widely accepted that the first immune system response to injury or infection is inflammation. However, when the inflammatory response is inappropriate, ineffective or excessive it can contribute to the development of a range of acute and chronic disease conditions. There are well-known signs of acute inflammation and a standard view on how to treat it. In this webinar, we will examine a new paradigm on treating inflammation and take a detailed look at the biological factors involved in the process.
This innovative and interesting webinar will discuss:
- Examining the paradigm shift in the treatment of acute inflammation changing the perception of a passive process
- The basic biology of inflammation and its resolution
- What immunoresolvins are and how they work on acute inflammatory responses
- How to measure inflammation resolution and the latest research surrounding this topic
$99 – 12 month membership which includes:
- Access all Live Webinars
- Ability to add and watch On Demand Webinars in your “My Library”
- Unlimited access for 12 months
1 Hour + Live Q&A
12 month membership includes 10+ CPE points
Accredited & Recognised by ANTA, ANPA & CMA
You will be redirected to bWellness, booking agent website
Presented by: Dr. Bernd Seilheimer
Bernd Seilheimer is a Neuroscientist by training. He postgraduated at the University of Heidelberg, Germany and Harvard Medical School, Boston, USA. He looks back at a long career in pharmaceutical industry (Hoffmann-La Roche, Schering AG, Bayer Schering Pharma) where he held several different management positions. From 2002-2010 he was a board member of the European Neuroscience Institute (ENI), Göttingen and from 2006 on a member of the Council of Scientific and Business Advisors of the Johnnie B. Byrd Institute, Florida, USA. He joined Biologische Heilmittel Heel GmbH in 2009.
In his role as Head of Systems Research and Development he is responsible for the broadening of the scientific knowledge base related to the company’s product portfolio. He makes sure that state-of-the-art technology platforms are applied and cooperations with centers of excellence are established.